期刊文献+

ROC曲线分析人附睾蛋白4在卵巢癌的诊断价值 被引量:1

Analysis of significance of human epididymal protein 4 in diagnosis of ovarian cancer by ROC curve
原文传递
导出
摘要 目的通过ROC曲线分析人附睾蛋白4(human epididymal protein 4,HE4)在卵巢癌的诊断价值。方法将107例卵巢疾病患者分为正常对照组(21例)、良性卵巢肿瘤组(20例)、Ⅰ-Ⅱ期卵巢癌组(14例)、Ⅲ期卵巢癌组(30例)、Ⅳ期卵巢癌组(22例)。分别对5组受试患者进行血清HE4水平测定和影像学检测,在灵敏性和特异性方面比较两者在卵巢癌诊断的价值;对各组患者血清HE4水平进行ROC曲线分析,评价血清HE4在卵巢癌诊断方面的价值。结果血清HE4水平检测在灵敏性上明显高于影像学检查,差异有统计学意义(P<0.05),而特异性差异无统计学意义(P>0.05),且血清HE4水平随着癌症恶性程度的增加而升高;ROC曲线线下面积AUG为0.912,具有较高的诊断价值。结论血清HE4水平检测在灵敏性上明显高于影像学检查,并且具有较好的特异性,可作为卵巢癌辅助检查手段,具有较高的临床诊断价值。 Objective To analyze the significance of human epididymal protein 4(HE4)in diagnosis of ovarian cancer by ROC curve. Methods A total of 107 patients with ovarian diseases were divided into normal control(21 cases), benign ovarian tumor(20 cases)as well as ovarian cancer of stagesⅠ- Ⅱ(14 cases), Ⅲ(30 cases)and IV(22 cases)groups,then determined for serum HE4 level and subjected to imaging examination. The two methods were evaluated for significance in diagnosis of ovarian cancer in terms of sensitivity and specificity. However, the serum HE4 levels in various groups were analyzed by ROC curve to evaluate such significance of HE4. Results The sensitivity of serum HE4 level was significantly higher than that of imaging examination(P〈0. 05), while the specificity of the former showed no significant difference with that of the latter(P〉0. 05). The serum HE4 level increased with the increasing malignancy.The AUG of ROC curve was 0. 912, indicating an important significance in diagnosis of ovarian cancer. Conclusion Serum HE4 level showed higher sensitivity than imaging examination, as well as high specificity, which might be used for assistant diagnosis of ovarian cancer, and of an important significance in diagnosis of ovarian cancer.
出处 《中国生物制品学杂志》 CAS CSCD 2017年第10期1063-1065,共3页 Chinese Journal of Biologicals
关键词 ROC曲线 人附睾蛋白4 卵巢癌 影像学诊断 ROC curve Human epididymal protein 4 (HE4) Ovarian cancer Imaging diagnosis
  • 相关文献

参考文献3

二级参考文献36

  • 1Ozols RF, Bookman MA, Connolly DC, et al, Focus on epithelial ovarian cancer. Cancer Cell, 2004,5 : 19-24.
  • 2Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002,359: 572-577.
  • 3Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HFA (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res, 2003, 63:3695-3700.
  • 4Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol, 2009,112:40-46.
  • 5Kirchhoff C, Habben I, Ivell R, et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod 1991, 45:350-357.
  • 6Drapkin R,Von Horsten HH, Lin YF, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 2005,65:2162-2169.
  • 7Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol, 2008,108:402-408.
  • 8Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HFA expression in normal and malignant human tissues [J]. Mod Pathol, 2006, 19: 847-853.
  • 9Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HFA ( WFD- C2 ) protein is a biomarker for ovarian carcinoma [ J ]. Cancer Res, 2003, 63: 3695-3700.
  • 10Bingle L, Singleton V, Bingle CD. The putative ovarian tumour marker gene HFA- (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms[J]. Oncogene, 2002, 21 (17) : 2768-2773.

共引文献120

同被引文献8

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部